CSF-1 and its receptor in ovarian, endometrial and breast cancer

Annals of Medicine

Volumn 27, Issue 1, 1995, Pages 79-85

  Kacinski, Barry M ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

Breast; CSF 1; Female reproductive tract; Neoplasm; Receptor; Tumour cells

Indexed keywords

GROWTH FACTOR; LIGAND; RECEPTOR; STEROID HORMONE; UROKINASE;

BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CELL MATURATION; ENDOMETRIUM CANCER; EXTRACELLULAR FLUID; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MACROPHAGE; MONOCYTE; NIDATION; ONCOGENE; OVARY CANCER; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; TROPHOBLAST;

BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMAN; MACROPHAGE COLONY-STIMULATING FACTOR; OVARIAN NEOPLASMS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 0028902228     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899509031941     Document Type: Article

References (59)

1. Cancer statistics
2. Cancer of the ovary
3. Epithelial carcinoma of the ovary: prognostic importance of histologic grade
4. Gynecologic tumours
5. Prognosis and treatment of endometrial cancer
6. The results of radical operations for the cure of cancer of the breast
7. Number of lymph nodes examined and the prognosis of breast cancer
8. Node negative breast cancer: prognostic subgroups defined by tumour size and flow cytometry
9. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
10. Neu protein overexpression in breast cancer: Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer
11. Over-expression of HER-2/neu in endometrial cancer is associated with advanced stage disease
12. NEU protein overexpression benign, borderline and malignant ovarian neoplasms
13. Expression of NEU antigen in normal lactating and pre-partum mammary epithelial cells
14. Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185-erbB2
15. High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas
16. Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumours
17. Oncogene structure, function and expression in breast cancer
18. The unique insert of cellular and viral fms protein tyrosine kinase is dispensable for enzymatic and transforming activity
19. The human hematopoietic colony stimulating factors
20. Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines
21. Apparent role of the macrophage growth factor CSF-1 in placental development
22. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility
23. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoieitic growth factor release by tumour cells?
24. The biology of CSF-1 and its receptor
25. Anti-colony stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory infiltrates and prognosis
26. Expression of colony stimulating factor-1 and its receptor (the protein product of c-fms) in invasive breast tumour cells. Induction of urokinase production via this pathway?
27. Is colony-stimulating factor-1 a key mediator of breast cancer invasion and metastasis?
28. The urokinase-type plasminogen activator (u-PA) is related to early relapse in breast cancer
29. Urokinase plasminogen activator and prognosis in breast cancer
30. The cytokine CSF-1 (M-CSF), whose receptors are expressed by endometrial carcinomas in vivo in vitro, may also be a circulating tumour marker of neoplastic disease activity in endometrial carcinoma patients
31. Circulating levels of CSF-1 (M-CSF), a lymphohematopoietic cytokine, may be a useful marker of disease status in patients with malignant ovarian neoplasms
32. The macrophage colony stimulating factor CSF-1 is produced by human ovarian and endometrial adenocarcinoma-derived cell lines and is present at abnormally high levels in the plasma of ovarian carcinoma patients with active disease
33. Macrophage colony-stimulating factor 1 (CSF-1) a clinically useful tumour marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen
34. The macrophage colony stimulating factor CSF-1, an auto- and paracrine tumour cytokine, is also a circulating ‘tumour marker’ in patients with ovarian, endometrial, and pulmonary neoplasms
35. Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival
36. Ovarian adenocarcinomas express FMS-complementary transcripts and FMS antigen in vivo in vitro, often with co-expression of CSF-1
37. fms (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo in vitro
38. CSF-1 stimulates Ishikawa cell proliferation and lipocortin synthesis
39. Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype
40. A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential
41. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus
42. Nucleotide sequence and structural organisation of the human fms proto-oncogene
43. Expression of transcripts for CSF-1 and for the ‘macrophage’ and ‘epithelial’ isoforms of the CSF-1R transcripts in human ovarian carcinomas
44. CSF-1 and c-fms gene expression in human carcinoma cell lines
45. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines
46. Human CSF-1: Molecular cloning and expression of a 4 kb cDNA encoding the human urinary protein
47. Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor (CSF-1)-positive cancer cell lines
48. Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1
49. Post-transcriptional regulation of c-fms proto-oncogene expression by dexamethasone and of CSF-1 in human breast carcinomas in vitro
50. Transcription of the human colony-stimulating factor-1 receptor gene is regulated by separate tissue-specific promoters
51. Transcriptional regulation of the c-fms (CSF-1 R) proto-oncogene in human breast carcinoma cells by glucocorticoids
52. The first intron of human c-FMS proto-oncogene contains a processed pseudogene for the ribosomal protein L7
53. Epidermal growth factor receptors in human breast cancer
54. Origins of human cancer revisited
55. neu: a potential model for receptor interactions
56. The epidermal growth factor receptor and the product of the NEU protooncogene are members of a receptor tyrosine phosphorylation cascade
57. neu/erbB-2 and the epidermal growth factor receptor
58. Regulation of MHC class II gene expression in macrophages by hematopoietic colony-stimulating factors (CSF)
59. A highly immunogenic tumour transfected with a murine transforming growth factor type beta cDNA escapes immune surveillance